Keohane P P, Attrill H, Grimble G, Spiller R, Frost P, Silk D B
JPEN J Parenter Enteral Nutr. 1983 Jul-Aug;7(4):346-50. doi: 10.1177/0148607183007004346.
Ten patients with histologically proven cirrhosis, admitted in grade I to II acute hepatic coma, received in addition to a standard dietary protein free "anticoma" regime, a continuous nasogastric infusion of a branched-chain amino acid enriched chemically defined enteral diet (Hepaticaid) containing an equivalent of 70 g protein/day for a mean of 7.3 days (range 3-23). No complications of therapy were observed and, specifically, the use of fine bore tubes did not provoke variceal hemorrhage. Overall positive nitrogen balance (4.3 +/- 1.7 g N/day) was observed in patients fed 7 or more days. Improvement to coma grade 0 was seen in all patients save one, who died from hepatorenal failure. While serum ammonia levels remained elevated during the study period, there was a significant increase in the branched-chain/aromatic ratio (p less than 0.01) as plasma branched-chain amino acids rose (p less than 0.05) and tyrosine levels fell (p less than 0.05).
十名经组织学证实为肝硬化的患者,以I至II级急性肝昏迷入院,除了接受不含蛋白质的标准“抗昏迷”饮食方案外,还通过鼻胃管持续输注一种富含支链氨基酸的化学定义肠内饮食(肝安),相当于每天70克蛋白质,平均持续7.3天(范围3 - 23天)。未观察到治疗并发症,具体而言,使用细孔管未引发静脉曲张出血。接受喂养7天或更长时间的患者观察到总体正氮平衡(4.3±1.7克氮/天)。除一名死于肝肾衰竭的患者外,所有患者均改善至0级昏迷。虽然研究期间血清氨水平仍升高,但随着血浆支链氨基酸升高(p<0.05)和酪氨酸水平下降(p<0.05),支链/芳香族氨基酸比值显著增加(p<0.01)。